2006
DOI: 10.1159/000098210
|View full text |Cite
|
Sign up to set email alerts
|

Advanced Glycation End Product in Diabetic Rat Skeletal Muscle in vivo

Abstract: Background: Advanced glycation end products (AGEs) are implicated in the etiology of diabetic complications in the kidney, nerve and eye. Skeletal muscle contractile parameters have also been found to be altered in diabetes. Glycation has not been extensively studied in skeletal muscle, but AGE-modified proteins may influence contractility. Objective and Methods: The aim of this study was to use immunohistochemistry to identify distribution patterns of the AGE NΕ-(carboxymethyl)-lysine in plantaris muscle of d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
29
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 27 publications
(34 citation statements)
references
References 39 publications
4
29
0
1
Order By: Relevance
“…Negative controls were performed by completing the immunolabeling procedure, but with elimination of the primary antibody incubation step. The preparation and CML immunolabeling of the soleus muscle were performed in identical manner to that of the plantaris, which has been previously described [24] .…”
Section: Tissue Staining and Analysismentioning
confidence: 99%
See 3 more Smart Citations
“…Negative controls were performed by completing the immunolabeling procedure, but with elimination of the primary antibody incubation step. The preparation and CML immunolabeling of the soleus muscle were performed in identical manner to that of the plantaris, which has been previously described [24] .…”
Section: Tissue Staining and Analysismentioning
confidence: 99%
“…AGEs have also been identified as markers of oxidative stress [17,19,20] . N -(carboxymethyl)-lysine (CML) is a non-cross-linking AGE that is present in vivo [15,21,22] and has been studied in animal models [23,24] .…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Advanced glycation end products also accumulate in the skeletal muscle of diabetic animals (Snow et al, 2006). Although the levels of both SERCA2a and its inhibitor phospholamban decrease in diabetes, the phospholamban/SERCA2a ratio becomes higher Our results suggest that the SERCA2a protein level is an earlier marker than that of MyHC1 for muscle diabetes.…”
Section: Diabetic Modelmentioning
confidence: 56%